KARYOTYPE ANALYSIS OF ADVANCED THERAPY SPECIMENS IN A ROUTINE CYTOGENETIC LABORATORY
Objectives: Cytogenetic study is a prerequisite for the therapeutic use of cellular/advanced therapy products required by regulatory agencies (ANVISA). This aims to guarantee the safety and quality of the cells for clinical use, preventing the use of extensive cell manipulations with chromosomal alt...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2023-10-01
|
| Series: | Hematology, Transfusion and Cell Therapy |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2531137923011264 |